PetVivo Holdings, Inc.

NASDAQ:PETV

$1.122 USD

-$0.08 (-6.48%)

Volume
2.51K
Average Volume
58.72K
Market Capitalization
$18.82M
P/E Ratio
-1.51
Dividend Yield
0.00%
Price Target
$
Year High
$3.60
Year Low
$0.55
Payout Ratio
$0.00
Current Ratio
$0.90

Industry, Sector & symbol

Stock Exchange NASDAQ Capital Market
CEO Mr. John Lai
Industry Medical Devices
Sector Healthcare
Current Symbol PETV
CUSIP 716817408
CIK 0001512922
Web https://www.petvivo.com
Phone 952 405 6216
Currency USD
Employees 25
Country US

Liquidity

Debt-to-Equity Ratio 1.56
Payout Ratio 0.00
Current Ratio 0.90
Quick Ratio 0.36
Cash Ratio 0.05

Sales & Book Value

Annual Sales $917.16K
Price / Sales 17.99
Cash Flow -0.53
Price / Cash Flow -2.48
Price / Book 17.89

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Buy
Rating Score(0-5) 4
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.85
Trailing P/E Ratio -1.51
PEG Ratio -0.06
P/E Growth -0.06
Net Income $-8.7M
Net Margin -1016.55%
Pretax Margin -1016.55%
Return on Equity -1414.49%
Return on Assets -292.95%

Financials Score

AltmanZ Score -35.98
Piotroski Score 3.00
Working Capital -169.24K
Total Assets 3.63M
Ebit -9.91M
Market Cap 16.93M
Total Liabilities 2.73M

Poll Results

About PetVivo Holdings, Inc. (NASDAQ:PETV) Stock

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. ...

PetVivo Holdings, Inc. (PETV) Q3 2024 Earnings Call Transcript

2024-02-12 22:04:07

PetVivo Holdings, Inc. (PETV) Q3 2024 Earnings Call Transcript

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

2024-02-06 12:37:00

MINNEAPOLIS, MN, US, Feb. 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Monday, February 12, 2024 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.

PetVivo Holdings, Inc. (PETV) Q2 2024 Earnings Call Transcript

2023-11-14 18:46:05

PetVivo Holdings, Inc. (NASDAQ:PETV ) Q2 2024 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - Chief Executive Officer & President Bob Folkes - Chief Financial Officer Conference Call Participants Operator Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year Second Quarter Earnings Report. This is November 14, 2023, and I will now hand over to Mr.

PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C.

2023-09-05 08:00:00

MINNEAPOLIS, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for pets, is pleased to announce it will be featured as a presenting company at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwright & Co. is hosting its 25th Annual Global Investment Conference, which is being held on September 11 to 13, 2023.

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE FIRST QUARTER ENDED June 3, 2023

2023-08-07 13:50:00

MINNEAPOLIS, MN, US, Aug. 07, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, August 10, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day.

Frequently Asked Questions

What is the current PetVivo Holdings, Inc. (PETV) stock price?

PetVivo Holdings, Inc.(NASDAQ:PETV) stock price is $1.122 in the last trading session. During the trading session, PETV stock reached the peak price of $3.6 while $0.55 was the lowest point it dropped to. The percentage change in PETV stock occurred in the recent session was --6.48% while the dollar amount for the price change in PETV stock was -$-0.08.

PETV's industry and sector of operation?

The NASDAQ listed PETV is part of Medical Devices industry that operates in the broader Healthcare sector.

Who are the executives of PETV?

Mr. John Lai | Chief Executive Officer, President & Director
Mr. Randall A. Meyer | Chief Operating Officer
Mr. Randy Wenthold | Chief Science Officer
Mr. John F. Dolan | General Counsel, Chief Business Development Officer & Secretary
Mr. Gary DeMel | Executive Vice President of Business Development

How many employees does PETV have?

Number of PETV employees currently stands at 25. PETV operates from 5251 Edina Industrial Boulevard, Minneapolis, MN 55439, US.

Link for PETV official website?

Official Website of PETV is: https://www.petvivo.com

How do I contact PETV?

PETV could be contacted at phone #952 405 6216 and can also be accessed through its website. PETV operates from 5251 Edina Industrial Boulevard, Minneapolis, MN 55439, US.

How many shares of PETV are traded daily?

The average number of PETV shares traded daily for last 3 months was 58.72K.

What is the market cap of PETV currently?

The market value of PETV currently stands at $18.82M with its latest stock price at $1.122